These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38537394)

  • 1. Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study.
    Ghafouri M; Duque L; Rodriguez LP; Philbrick KL; Savica R; Pazdernik VK; Port JD; Rummans TA; Singh B
    Schizophr Res; 2024 May; 267():138-140. PubMed ID: 38537394
    [No Abstract]   [Full Text] [Related]  

  • 2. Single case study of brain FDG PET imaging in a patient with catatonia.
    Breker D; Bohnen NI
    Clin Nucl Med; 2013 Jul; 38(7):e297-8. PubMed ID: 23603588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia.
    Bralet MC; Buchsbaum MS; DeCastro A; Shihabuddin L; Mitelman SA
    Eur Arch Psychiatry Clin Neurosci; 2016 Sep; 266(6):481-94. PubMed ID: 26370275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probable Autoimmune Catatonia With Antibodies Against Cilia on Hippocampal Granule Cells and Highly Suspicious Cerebral FDG-Positron Emission Tomography Findings.
    Endres D; Prüss H; Rauer S; Süß P; Venhoff N; Feige B; Schweizer T; Nickel K; Maier S; Egger K; Domschke K; Meyer PT; Tebartz van Elst L
    Biol Psychiatry; 2020 May; 87(9):e29-e31. PubMed ID: 32122620
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study.
    Mehta NN; Yu Y; Saboury B; Foroughi N; Krishnamoorthy P; Raper A; Baer A; Antigua J; Van Voorhees AS; Torigian DA; Alavi A; Gelfand JM
    Arch Dermatol; 2011 Sep; 147(9):1031-9. PubMed ID: 21576552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive transcranial magnetic stimulation for the treatment of catatonia: an alternative treatment to electroconvulsive therapy?
    Trojak B; Meille V; Bonin B; Chauvet-Geliner JC
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E42-3. PubMed ID: 24763790
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
    Vijverberg EG; Wattjes MP; Dols A; Krudop WA; Möller C; Peters A; Kerssens CJ; Gossink F; Prins ND; Stek ML; Scheltens P; van Berckel BN; Barkhof F; Pijnenburg YA
    J Alzheimers Dis; 2016 Jun; 53(4):1287-97. PubMed ID: 27372646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement.
    Iwamuro M; Okada H; Takata K; Shinagawa K; Fujiki S; Shiode J; Imagawa A; Araki M; Morito T; Nishimura M; Mizuno M; Inaba T; Suzuki S; Kawai Y; Yoshino T; Kawahara Y; Takaki A; Yamamoto K
    World J Gastroenterol; 2012 Nov; 18(44):6427-36; discussion p.6434. PubMed ID: 23197888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Metabolic Brain Pattern Associated With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
    Kerik-Rotenberg N; Diaz-Meneses I; Hernandez-Ramirez R; Muñoz-Casillas R; Reynoso-Mejia CA; Flores-Rivera J; Espinola-Nadurille M; Ramirez-Bermudez J; Aguilar-Palomeque C
    Psychosomatics; 2020; 61(1):39-48. PubMed ID: 31611047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.
    Foster NL; Wang AY; Tasdizen T; Fletcher PT; Hoffman JM; Koeppe RA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S29-36. PubMed ID: 18631997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive Therapy in a Patient With Chronic Catatonia: Clinical Outcomes and Cerebral 18[F]Fludeoxyglucose Positron Emission Tomography Findings.
    Pigato G; Roiter B; Cecchin D; Morbelli S; Tenconi E; Minelli A; Bortolomasi M
    J ECT; 2016 Dec; 32(4):222-223. PubMed ID: 27356089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F-FDG PET in the diagnosis of large vessel vasculitis].
    Rehák Z; Fojtík Z; Stanícek J; Bolcák K; Frysáková L
    Vnitr Lek; 2006 Nov; 52(11):1037-44. PubMed ID: 17165522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of fluorodeoxyglucose-positron emission tomography for the differentiation of cerebral lesions in patients with acquired immune deficiency syndrome.
    Menendez JA; Lilien DL; Nanda A; Polin RS
    Neurosurg Focus; 2000 Feb; 8(2):e2. PubMed ID: 16869549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    Inui Y; Ito K; Kato T;
    J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.